Guardant Health Inc. is exploring an acquisition of cancer diagnostics and testing firm NeoGenomics Inc., according to people familiar with the matter. NeoGenomics rose more than 13 percent on the news.
To read the entire story, you must be logged in.
Please log in now or register with us.
